Target intelligence / Profile preview

Cellular and endosomal lipid bilayers

Molecular classification
Lipid bilayer, Biological membrane, Phospholipid assembly
01

Overview

Cellular and endosomal lipid bilayers are fundamental structural components of eukaryotic cells, consisting primarily of a double layer of phospholipids interspersed with proteins and cholesterol. They serve as selective barriers that regulate the passage of ions and molecules, maintaining cellular homeostasis and facilitating compartmentalization (StatPearls, 2023). In pharmacology, these bilayers are critical targets for antimicrobial agents, such as Amphotericin B and Daptomycin, which disrupt membrane integrity to induce cell death in pathogens (PubMed, PMID: 23027178). Furthermore, they are central to the efficacy of modern drug delivery systems like lipid nanoparticles (LNPs); these systems interact with endosomal membranes to facilitate the cytosolic delivery of nucleic acids through endosomal escape (Nature Reviews Drug Discovery, 2021). Dysregulation of membrane composition or trafficking is implicated in various pathologies, including viral infections, where pathogens exploit these bilayers for entry, and respiratory distress syndrome, where surfactant deficiency leads to alveolar collapse (NIH, 2022).

Other names
Biological membranesPlasma membraneEndosomal membranePhospholipid bilayerCytoplasmic membrane
02

Mechanism of action

Drugs targeting lipid bilayers typically act through pore formation, physical disruption of membrane integrity, alteration of membrane fluidity, or by facilitating endosomal escape via membrane fusion or the proton sponge effect. In the case of surfactants, they reduce surface tension at the air-liquid interface of the alveoli.

03

Biological functions

CompartmentalizationSelective permeabilitySignal transductionEndocytosisExocytosisVesicular transportIon homeostasis
04

Disease associations

InfectionRespiratory distress syndromeLysosomal storage diseaseCancerNeurodegenerative disease
05

Safety considerations

Off-target membrane disruptionHemolysisCytotoxicityImmunogenicity of lipid nanoparticlesSystemic toxicity due to non-specific binding
06

Interacting drugs

Amphotericin B

7 more in the full profile.

07

Biomarkers

Membrane fluidityLipidomic profileEndosomal pHAnnexin V binding

Beyond the preview

Go deeper on Cellular and endosomal lipid bilayers.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cellular and endosomal lipid bilayers.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call